Susan E Graf's Net Worth

$527 Thousand

Estimate Recalculated Jun 10, 2024 06:01PM EST

Who is Susan E Graf?

Susan E Graf does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Finch Therapeutics Group, Inc., Epizyme, Inc., and NPS PHARMACEUTICALS INC.

SEC CIK

Susan E Graf's CIK is 0001577637

Past Insider Trading and Trends

2014 was Susan E Graf's most active year for acquiring shares with 3 total transactions. Susan E Graf's most active month to acquire stocks was the month of January. 2015 was Susan E Graf's most active year for disposing of shares, totalling 10 transactions. Susan E Graf's most active month to dispose stocks was the month of January. 2015 saw Susan E Graf paying a total of $99,993.90 for 19,061 shares, this is the most they've acquired in one year. In 2015 Susan E Graf cashed out on 98,650 shares for a total of $549,031.64, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Finch Therapeutics Group, Inc. (FNCH) Snapshot price: $2.77

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
5.01K
$0.27
$1,352.70
5.01K
Jun 8 - Jun 9
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Apr 23
Form 3
—
0
—
—
0
No matching records found

Epizyme, Inc. No price found

Chief Business Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 9
Form 4
—
0
—
—
0
Feb 8
Form 4
—
0
—
—
0
Apr 25
Form 3
—
0
—
—
0
No matching records found

NPS PHARMACEUTICALS INC No price found

VP,Corp Development & Strategy

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-4.76K
$46.00
-$219,006.00
0
Feb 21
Form 4
+25.29%
961
$45.85
-$22,191.40
4.76K
Feb 12
Form 4
—
0
$30.39
-$207,840.34
3.8K
Feb 10
Form 4
∞
3.8K
$33.10
-$65,802.80
3.8K
Jun 17
Form 4
—
0
—
—
0
Feb 12
Form 4
—
0
—
—
0
Jun 17
Form 3
—
0
—
—
0
No matching records found

CG Oncology, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found